20/20 Genesystems, Inc.

Rockville, MD 20850

SBIR Award Summary

Total Number of Awards 11
Total Value of Awards $4.13MM
First Award Date 09/20/04
Most Recent Award Date 09/01/12

Key Personnel

Last Name Name Awards Contact
Barbari Timothy A. Barbari 1
Hirschowitz Edward A Hirschowitz 1
Lebowitz Michael Lebowitz 2
James William M James 3
Khattar Nada H Khattar 3
Gillespie John Gillespie 1

11 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-10-009
Budget: 09/01/12 - 08/31/13

Project Summary The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treatments. 20/20 GeneSystems, Inc. (20/20) is a small business concern focused on the development of diagnostics for personalized medicine. Towards this end, 20/20 has dev...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-10-009
Budget: 09/08/11 - 08/31/12

DESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treatments. 20/20 GeneSystems, Inc. (20/20) is a small business concern focused on the development of diagnostics for personalized medicine. Towards thi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-10-009
Budget: 09/24/10 - 08/31/11

DESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treatments. 20/20 GeneSystems, Inc. (20/20) is a small business concern focused on the development of diagnostics for personalized medicine. Towards thi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-280
Budget: 08/27/09 - 07/31/10

DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create new "companion" diagnostics to better select patients likely to respond to targeted therapies, including Herceptin. and novel tyrosine kinase inhibit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/09 - 06/30/10

DESCRIPTION (provided by applicant): SBIR grant support is being sought by 20/20 GeneSystems, Inc. (20/20), a small biotech company, to help us advance what we believe will become the first blood test to be routinely employed to aid in the early detection of head and neck cancer. Despite recent advances in both diagnostic and therapeutic modalit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/09 - 09/30/10

DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a sufficiently early stage to be cured by surgical or other procedures. When used in concert with radiographic imaging, a sensitive and specific blo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 08/01/08 - 07/31/09

DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create new "companion" diagnostics to better select patients likely to respond to targeted therapies, including Herceptin. and novel tyrosine kinase inhibit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-07-80
Budget: 09/28/07 - 02/28/09

DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a sufficiently early stage to be cured by surgical or other procedures. When used in concert with radiographic imaging, a sensitive and specific blo...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 06/15/07 - 11/30/07

DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create new "companion" diagnostics to better select patients likely to respond to targeted therapies, including Herceptin(r) and novel tyrosine kinase inhib...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: RFA-CA-06-06
Budget: 07/13/06 - 06/30/07

DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically dismal outcomes. Circulating antibodies, generated to a wide range of tumor-associated proteins, can be translated into a valuable blood test for lun...

Load More